Correlates of lending needles/syringes among HIV-seropositive injection drug users

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue SUPPL. 2, 2007, Pages

  Metsch, Lisa R ^a   Pereyra, Margaret ^a   Purcell, David W ^b   Latkin, Carl A ^c   Malow, Robert ^d   Gómez, Cynthia A ^e   Latka, Mary H ^f  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

HIV; Injection drug use; Injection drug use equipment; Injection risk behavior; Seropositive

Indexed keywords

ADULT; ARTICLE; CORRELATION ANALYSIS; DRUG ABUSE; DRUG USE; FEMALE; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MENTAL HEALTH; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SELF REPORT; SOCIAL ASPECT; VIRUS TRANSMISSION;

ADULT; DATA COLLECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; NEEDLE SHARING; RISK FACTORS; SELF DISCLOSURE; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 37349000256     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181576818     Document Type: Article

References (58)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004, vol. 16. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2005.
2. Santibanez SS, Garfein RS, Swartzendruber A, et al. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006;83:86-100.
3. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874-879.
4. Chaisson RE, Moss AR, Onishi R, et al. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health. 1987;77:169-172.
5. Jose B, Friedman SR, Neaigus A, et al. Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS. 1993;7:1653-1660.
6. Samuels ME, Koop CE, Hartsock PI. Single-use syringes. N Engl J Med. 1991;324:996-997.
7. Wiebel WW, Jimenez A, Johnson W, et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a 4-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:282-289.
8. Vlahov D, Khabbaz RF, Cohn S, et al. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:89-96.
9. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645-653.
10. Hagan H, Thiede H, Weiss NS, et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42-46.
11. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987;1:39-44.
12. Battjes RJ, Leukefeld CG, Pickens RW. Age at first injection and HIV risk among intravenous drug users. Am J Drug Alcohol Abuse. 1992;18:263-273.
13. Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI): Administration, Scoring, and Procedure Manual - 1. Baltimore, MD: John Wiley; 1982.
14. Gibson DR, Choi KH, Catania JA, et al. Psychosocial predictors of needle sharing among intravenous drug users. Int J Addict. 1993;28:973-981.
15. Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:202-207.
16. Nelson KE, Vlahov D, Solomon L, et al. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD. Arch Intern Med. 1995;155:1305-1311.
17. Nicolosi A, Leite ML, Musicco M, et al. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) study. Am J Epidemiol. 1992;135:225-233.
18. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281-1288.
19. Nelson KE, Galai N, Safaeian M, et al. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol. 2002;156:641-653.
20. Avants SK, Warburton LA, Hawkins KA, et al. Continuation of high-risk behavior by HIV-positive drug users. Treatment implications. J Subst Abuse Treat. 2000;19:15-22.
21. Brogly SB, Bruneau J, Lamothe F, et al. HIV-positive notification and behavior changes in Montreal injection drug users. AIDS Educ Prev. 2002;14:17-28.
22. Deren S, Beardsley M, Tortu S, et al. HIV serostatus and changes in risk behaviors among drug injectors and crack users. AIDS Behav. 1998;2:171-176.
23. Diaz T, Chu SY, Weinstein B, et al. Injection and syringe sharing among HIV-infected injection drug users: implications for prevention of HIV transmission. Supplement to HIV/AIDS Surveillance Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S76-S81.
24. Metsch LR, McCoy CB, Lai S, et al. Continuing risk behaviors among HIV-seropositive chronic drug users in Miami, Florida. AIDS Behav. 1998;2:161-169.
25. Kwiatkowski CF, Booth RE. HIV-seropositive drug users and unprotected sex. AIDS Behav. 1998;2:151-159.
26. Inciardi JA, Surratt HL, Kurtz SP, et al. The effect of serostatus on HIV risk behaviour change among women sex workers in Miami, Florida. AIDS Care. 2005;17(Suppl 1):S88-S101.
27. Dolezal C, Meyer-Bahlburg HF, Liu X, et al. Longitudinal changes in sexual risk behavior among HIV+ and HIV-male injecting drug users. Am J Drug Alcohol Abuse. 1999;25:281-303.
28. McGowan JP, Shah SS, Ganea CE, et al. Risk behavior for transmission of human immunodeficiency virus (HIV) among HIV-seropositive individuals in an urban setting. Clin Infect Dis. 2004;38:122-127.
29. Des Jarlais DC, Perlis T, Arasteh K, et al. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr. 2004;35:158-166.
30. Purcell DW, Metsch LR, Latka M, et al. Interventions for seropositive injectors - research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S110-S118.
31. Unger JB, Kipke MD, De Rosa CJ, et al. Needle-sharing among young IV drug users and their social network members: the influence of the injection partner's characteristics on HIV risk behavior. Addict Behav. 2006;31:1607-1618.
32. Wolitski RJ, Bailey CJ, O'Leary A, et al. Self-perceived responsibility of HIV-seropositive men who have sex with men for preventing HIV transmission. AIDS Behav. 2003;7:363-372.
33. Rogers ES, Chamberlin J, Ellison ML, et al. A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv. 1997;48:1042-1047.
34. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley-Interscience; 2000.
35. Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injecting drug users: a review of published outcome data. Public Health Rep. 1998;113(Suppl 1):19-30.
36. Semaan S, Des Jarlais DC, Malow R. Behavior change and health-related interventions for heterosexual risk reduction among drug users. Subst Use Misuse. 2006;41:1349-1378.
37. Koester S, Glanz J, Baron A. Drug sharing among heroin networks: implications for HIVand hepatitis B and C prevention. AIDS Behav. 2005;9:27-39.
38. McCoy CB, Metsch LR, Chitwood DD, et al. Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S25-S29.
39. Fisher JD, Misovich SJ, Kimble DL, et al. Dynamics of HIV risk behavior in HIV-infected injection drug users. AIDS Behav. 1999;3:41-57.
40. Kozal MJ, Amico KR, Chiarella J, et al. HIV drug resistance and HIV transmission risk behaviors among active injection drug users. J Acquir Immune Defic Syndr. 2005;40:106-109.
41. Sethi AK, Celentano DD, Gange SJ, et al. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr. 2004;35:503-510.
42. Sulkowski MS, Thomas DL. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment. Clin Infect Dis. 2005;40(Suppl 5):S263-S269.
43. Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22:332-339.
44. Friedman SR, Maslow C, Bolyard M, et al. Urging others to be healthy: "intravention" by injection drug users as a community prevention goal. AIDS Educ Prev. 2004;16:250-263.
45. Valente TW, Vlahov D. Selective risk taking among needle exchange participants: implications for supplemental interventions. Am J Public Health. 2001;91:406-411.
46. Latkin C, Mandell W, Oziemkowska M, et al. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend. 1995;38:1-9.
47. Lundgren LM, Amodeo M, Chassler D. Mental health status, drug treatment use, and needle sharing among injection drug users. AIDS Educ Prev. 2005;17:525-539.
48. Johnson ME, Yep MJ, Brems C, et al. Relationship among gender, depression, and needle sharing in a sample of injection drug users. Psychol Addict Behav. 2002;16:338-341.
49. Mandell W, Kim J, Latkin C, et al. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. Am J Drug Alcohol Abuse. 1999;25:117-127.
50. Hawkins WE, Latkin C, Mandel W, et al. Do actions speak louder than words? Perceived peer influences on needle sharing and cleaning in a sample of injection drug users. AIDS Educ Prev. 1999;11:122-131.
51. Metzger D,Woody G, De Philippis D, et al. Risk factors for needle sharing among methadone-treated patients. Am J Psychiatry. 1991;148:636-640.
52. Brown LS Jr, Kritz SA, Goldsmith RJ, et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2006;30:315-321.
53. Lum PJ, Sears C, Guydish J. Injection risk behavior among women syringe exchangers in San Francisco. Subst Use Misuse. 2005;40:1681-1696.
54. Bogart LM, Kral AH, Scott A, et al. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sex Transm Dis. 2005;32:27-34.
55. Deren S, Kang SY, Colon HM, et al. HIV incidence among high-risk Puerto Rican drug users: a comparison of East Harlem, New York, and Bayamon, Puerto Rico. J Acquir Immune Defic Syndr. 2004;36:1067-1074.
56. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657-1661.
57. Latka MH, Metsch LR, Mizuno Y, et al. Unprotected sex among HIV-positive injection drug-using women and their serodiscordant male partners: role of personal and partnership influences. J Acquir Immune Defic Syndr. 2006;42:222-228.
58. Purcell DW, Mizuno Y, Metsch LR, et al. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. J Urban Health. 2006;83:656-668.